The prevention of the staurosporine-induced apoptosis by Bcl-XL, but not by Bcl-2 or caspase inhibitors, allows the extensive differentiation of human neuroblastoma cells

Journal of Neurochemistry

Volumn 80, Issue 1, 2002, Pages 126-139

  Yuste, Víctor J ^a   Sánchez López, Isabel ^a   Solé, Carme ^a   Encinas, Mario ^a   Bayascas, Jose R ^a   Boix, Jacint ^a   Comella, Joan X ^a  

^a UNIVERSITY OF LLEIDA   (Spain)

Author keywords

Bcl 2; Bcl XL; Caspases; Neuritogenesis; SH SY5Y cells; Staurosporine

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; CASPASE INHIBITOR; CYTOCHROME C; MICROTUBULE ASSOCIATED PROTEIN 2; NEUROFILAMENT PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; STAUROSPORINE; TAU PROTEIN;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME RELEASE; HUMAN; HUMAN CELL; MITOCHONDRION; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEUROBLASTOMA CELL; NEUROFILAMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

AMINO ACID CHLOROMETHYL KETONES; APOPTOSIS; BCL-X PROTEIN; CASPASES; CELL DIFFERENTIATION; ENZYME INHIBITORS; HUMANS; NEURITES; NEUROBLASTOMA; PROTO-ONCOGENE PROTEINS C-BCL-2; STAUROSPORINE; TUMOR CELLS, CULTURED;

EID: 0036273353     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-3042.2001.00695.x     Document Type: Article

References (55)

1. The BCL-2 protein family: Arbiters of cell survival
2. Anti-apoptotic oncogenes prevent caspase-dependent and independent commitment for cell death
3. The Bcl-2 protein family
4. L
5. Comparative effects of Bcl-2 over-expression and ZVAD.FMK treatment on dexamethasone and VP16-induced apoptosis in CEM cells
6. Characterization of the cell death process induced by staurospofine in human neuroblastoma cell lines
7. Serum deprivation and protein synthesis inhibition induce two different apoptotic processes in N18 neuroblastoma cells
8. Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers
9. Proteases to die for
10. Staumsporine-induced neuronal death: Multiple mechanisms and methodological implications
11. Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis
12. Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophie factorgives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells
13. +-induced apoptosis in human SH-SY5Y neuroblastoma cells
14. Cleavage of automodified poly (ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7
15. Bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death
16. Staurosporine-induced neurite outgrowth in PC12h cells
17. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death
18. Bcl-2, Bcl-XL and adenovirus protein ElB19kD are functionally equivalent in their ability to inhibit cell death
19. Staurosporine induces a neuronal phenotype in SH-SY5Y human neuroblastoma cells that resembles that induced by the phorbol ester 12-O-tetradecanoyl phorbol-13 acetate (TPA)
20. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an α-, β-, and ζ-protein kinase C-independent pathway
21. Caspase-3 is required for α-Fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis
22. L inhibits cytochrome c release but nor mitochondrial depolarization during activation of multiple death pathways by tumor necrosis factor-α
23. Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis
24. Proteolytic activities that mediate apoptosis
25. Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells
26. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
27. Staurosporine-induced neuronal apoptosis
28. Investigation of the subcellular distribution of the Bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes
29. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein
30. Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin
31. The mitochondrial death/life regulator in apoptosis and necrosis
32. β-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells
33. Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis
34. Overexpression of BCL-X(L) underlies the molecular basis for resistance to staurosporine-induced in PC-3 cells
35. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak
36. Bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation
37. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice
38. Targeted disruption of Bcl-2 alpha beta in mice: Occurrence of gray hair, polycystic kidney disease, and lymphocytpenia
39. The Bcl-2 protein family
40. Differentiation and survival influences of growth factors in human neuroblastoma
41. Late compartments of amyloid precursor protein transport in SY5Y cells are involved in beta-amyloid secretion
42. Characterization of CPP32-like protease activity following apoptotic challenge in SH-SY5Y neuroblastoma cells
43. 2+ and reactive oxygen species in staurosporine-enhanced neuronal apoptosis
44. Staurosporinerinduced neurite outgrowth in PC12 cells is independent of protein kinase C inhibition
45. Staurosporine induces the outgrowth of neurites from the dorsal root ganglion of the chick embryo and PC12D cells
46. + induced apoptotic cell death in SH-SY5Y neuroblastoma cells: An electron microscope study
47. Bcl-2 and Bcl-XL can differentially block chemotherapy-induced cell death
48. Apoptosis in the pathogenesis and treatment of disease
49. Caspases: Enemies within
50. Control of apoptosis by proteases
51. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair
52. Proapoptotic Bax and Bak: A requisite gateway to mitochondrial dysfunction and death
53. Assays for the measurement of DNA fragmentation during apoptosis
54. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
55. Absence of oligonucleosomal DNA fragmentation during apoptosis of IMR-5 neuroblastoma cells. Disappearance of the caspase-activated Dnase